BioXcel Therapeutics (BTAI) Leases (2022 - 2025)
BioXcel Therapeutics (BTAI) has 4 years of Leases data on record, last reported at $140000.0 in Q3 2025.
- For Q3 2025, Leases fell 69.63% year-over-year to $140000.0; the TTM value through Sep 2025 reached $140000.0, down 69.63%, while the annual FY2024 figure was $382000.0, 44.48% down from the prior year.
- Leases reached $140000.0 in Q3 2025 per BTAI's latest filing, down from $222000.0 in the prior quarter.
- Across five years, Leases topped out at $1.2 million in Q1 2022 and bottomed at $140000.0 in Q3 2025.
- Average Leases over 4 years is $677666.7, with a median of $688000.0 recorded in 2023.
- Peak YoY movement for Leases: fell 23.29% in 2023, then crashed 69.63% in 2025.
- A 4-year view of Leases shows it stood at $976000.0 in 2022, then fell by 29.51% to $688000.0 in 2023, then tumbled by 44.48% to $382000.0 in 2024, then crashed by 63.35% to $140000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $140000.0 in Q3 2025, $222000.0 in Q2 2025, and $303000.0 in Q1 2025.